Ninlib 150 mg Ninlib 150 mg contains Nilotinib 150 mg, a targeted medicine used mainly for treating certain forms of chronic myeloid leukemia (CML). It works by blocking the abnormal protein responsible for sending continuous growth signals to leukemia cells. By reducing these signals, the medicine helps control the production and multiplication of abnormal blood cells and supports better management of the disease over time. It is taken orally according to a treatment schedule determined by the oncologist.